Trial
NCT06532136
Deucravacitinib Rosacea
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Bristol-Myers Squibb
Condition
Papulopustular Rosacea
Intervention
Deucravacitinib
Why stopped
This study is being closed due to sponsor withdrawal of funding and support.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-24